SCHEMBL10568294

SCHEMBL10568294

COc1ccc(-c2cc(=O)n(C)c(=O)n2C)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MAPT P10636 4/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4C Q9H3R0 1/20 0.48
▸ HTT P42858 1/20 0.47
▸ CYP19A1 P11511 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ NQO2 P16083 2/20 0.44
▸ THRB P10828 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ S100B P04271 1/20 0.42
▸ PDE4A P27815 4/20 0.42
▸ PDE4B Q07343 3/20 0.41
▸ PDE4C Q08493 3/20 0.41
▸ PDE4D Q08499 3/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10567603 0.84 KDM4E (0.42) TSHRL3MBTL1MAPTALDH1A1CYP19A1
SCHEMBL10364624 0.84 L3MBTL1 (0.40) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10565552 0.84 ALDH1A1 (0.44) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10564675 0.83 PDE4B (0.45) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10564660 0.82 CYP19A1 (0.47) TSHRL3MBTL1ALDH1A1HTTCYP19A1
SCHEMBL10725957 0.82 PDGFRB (0.45) MAPTALDH1A1HTT
SCHEMBL10567284 0.80 MAPT (0.48) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10564957 0.79 ALDH1A1 (0.39) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10564960 0.79 ALDH1A1 (0.39) TSHRL3MBTL1MAPTALDH1A1KDM4C
SCHEMBL10567745 0.79 CYP3A4 (0.53) MAPTALDH1A1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4649142-A 3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-03-10 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0166564-A2 Pyrimidone derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback